liver cancer

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

liver cancer
Jun 24, 2025, 06:41 | Blog
GENIAL Project Explores Gene–Environment Links in Alcohol-Related Liver Cancer
GENIAL - Horizon Europe posted on LinkedIn: "What is the GENIAL Project all about? GENIAL…
Jun 18, 2025, 15:34 | Insight
Amol Akhade: Top Sessions to Watch at ESMO GI 2025 – Clinical Innovation Meets Pragmatism
Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics, posted on LinkedIn: "Top Sessions to…
Jun 12, 2025, 09:34 | Blog
ELPA Brought Together Experts to Address Liver Disease and Preventable NCDs in Europe
European Liver Patients'​ Association - ELPA shared a post on LinkedIn: "Prevention is not only…
May 30, 2025, 14:31 | Blog
The Time for Liver Health Action is NOW - European Liver Patients'​ Association
European Liver Patients'​ Association - ELPA shared a post on LinkedIn: "The Time for Liver…
May 29, 2025, 22:49 | Blog
European Liver Patients'​ Association: The Role of Research and Innovation in Advancing Liver Cancer Therapies
European Liver Patients'​ Association - ELPA shared a post on LinkedIn: "Research = HOPE. We’re…
May 29, 2025, 22:12 | Opinion
ELPA Highlight Liver Cancer Awareness and Prevention During European Week Against Cancer
European Liver Patients'​ Association - ELPA shared a post on LinkedIn: "Proud moments and powerful…
May 2, 2025, 10:51 | Blog
Beau Bosko Toskich: Combining Local Therapy and Immunotherapy in Intermediate Stage HCC
Beau Bosko Toskich, Professor of Radiology and Director of Interventional Oncology at Mayo Clinic Florida,…
May 2, 2025, 10:42 | Science
How PLT012 can Rejuvenate Antitumor Immunity to Reprogram the Immune landscape of Liver Cancer - Cancer Research Institute
Cancer Research Institute (CRI) shared an article on LinkedIn: "Despite the success of cancer immunotherapies, such…
Apr 30, 2025, 13:49 | Drugs
Cabozantinib: What patients need to know?
Cabozantinib is a targeted therapy used to treat various types of cancer. This oral medication…
Apr 25, 2025, 12:50 | Science
Arndt Vogel: First-Line Atezolizumab plus Bevacizumab for HCC in Asia-Pacific
Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology at Hannover Medical…
Apr 20, 2025, 02:27 | Blog
Let’s Talk About Liver Cancer – On World Liver Day
Today is World Liver Day, a time to show some love to one of the…
Apr 16, 2025, 06:37 | Blog
ESMO Gastrointestinal Oncology calls for papers - Oncology Advance
Oncology Advance shared a post on X: "ESMO Gastrointestinal Oncology invites submissions for special issues…
Apr 12, 2025, 15:58 | Oncolibrary
FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial
April 11, 2025 — The U.S. Food and Drug Administration (FDA) has approved the combination…
Apr 3, 2025, 09:59 | Blog
Arndt Vogel: Neratinib alone has no effect, but are the combinations promising?
Arndt Vogel, Director of the Center for Personalized Medicine at Hannover Medical School, shared a…
Mar 30, 2025, 19:05 | Blog
New Council Recommendation on Vaccine-Preventable Cancers - European Cancer Organisation
European Cancer Organisation shared a post on LinkedIn: "Great discussions at the technical meeting of…
Mar 15, 2025, 13:53 | Blog
Erman Akkus: The 3rd International Liver Days in Istanbul
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: "3rd International…
Mar 12, 2025, 08:59 | Blog
Investing in liver health means investing in the future of public health - ELPA
European Liver Patients'​ Association - ELPA posted on LinkedIn: "A Transformative Week in Brussels! This…
Mar 11, 2025, 06:28 | Blog
ELPA at the Heart of Europe - Shaping the Future of Liver Health
European Liver Patients'​ Association - ELPA shared a post on LinkedIn: "ELPA at the Heart…
Mar 4, 2025, 09:00 | Blog
Milan Mishkovikj: A Historic Step Forward in the Fight Against Liver Cancer
Milan Mishkovikj, President of the National Alliance of Patient Organizations (NAPO), shared a post on…
Mar 3, 2025, 10:57 | Blog
Marco Donia: RNA splicing generates cancer neoantigens, beyond mutations
Marco Donia, Associate Professor in Clinical Oncology at the University of Copenhagen, shared a post…
Feb 28, 2025, 08:42 | Science
A new class of tumor-wide public neoantigens arising from RNA splicing aberrations - Cancer Research Institute
Cancer Research Institute (CRI) shared an article by Darwin W. Kwok, et al. on LinkedIn:…
Feb 11, 2025, 15:08 | Blog
Gratitude and Hope: Together, We Fight Liver Cancer - European Liver Patients' Association
European Liver Patients' Association shared a post on X:  Gratitude & Hope: Together, We Fight…
Feb 8, 2025, 14:06 | Insight
Shahrin Ahmed: Liver cancer risk rises after successful DAA therapy for HCV
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: "The…
Feb 7, 2025, 19:07 | Blog
Liver cancer patients need our support, our voices, and our action - ELPA
European Liver Patients'​ Association (ELPA) shared a post on LinkedIn: "Join the Fight Against Liver…
Feb 5, 2025, 17:32 | Blog
Unite for a future free of liver cancer - ELPA
European Liver Patients'​ Association - ELPA posted on LinkedIn: "UNITE FOR A FUTURE FREE OF…
Feb 4, 2025, 17:30 | Blog
World Cancer Day 2025: A Historic Moment in the Fight Against Liver Cancer - ELPA
European Liver Patients'​ Association - ELPA posted on LinkedIn: "World Cancer Day 2025: A Historic…
Jan 30, 2025, 18:06 | Blog
A chance for Europe to lead the way, united and unique, in building a healthier and stronger future - ELPA
European Liver Patients’​ Association shared a post on LinkedIn: "Incredible strides for liver health! It…
Jan 17, 2025, 15:10 | Blog
The countdown to World Cancer Day begins - European Liver Patients'​ Association
European Liver Patients'​ Association - ELPA shared a post on LinkedIn: "The Countdown to World…
Jan 16, 2025, 23:23 | Blog
Marina Uchenik: The annual Blue Faery Award for Excellence in Liver Cancer Research
Marina Uchenik, Operations Manager at Blue Faery The Adrienne Wilson Liver Cancer Association, shared a…
Jan 11, 2025, 09:26 | Blog
Liver Cancer: One of the Most Preventable Cancers - ELPA
European Liver Patients'​ Association - ELPA shared a post on LinkedIn: "Liver Cancer - One…
Jan 5, 2025, 13:25 | Blog
Your Choices Matter: Break the Deadly Cycle - ELPA
European Liver Patients'​ Association - ELPA shared a post on LinkedIn: "Your Choices Matter: Break…
Jan 4, 2025, 16:51 | Insight
Exploring the Role of FBP1 in the Transition from Fatty Liver Disease to Hepatocellular Carcinoma
A study published in Nature uncovered a complex connection between cellular metabolism and DNA damage,…
Jan 3, 2025, 16:51 | Science
Melinda Bachini: Advancing Patient-Centered Care in Transplant Oncology
Melinda Bachini, Director of Patient Services and Chief Patient Officer at Cholangiocarcinoma Foundation, shared a…
Jan 1, 2025, 09:39 | Blog
This New Year, Choose Health Over Harm! - ELPA
European Liver Patients'​ Association - ELPA posted on LinkedIn: "This New Year, Choose Health Over…
Dec 27, 2024, 03:54 | Blog
Shaibu Issa: History in the making at MUHAS
Shaibu Issa, Member HBV Global Community Advisory Board at Hepatitis B Foundation, shared a post…
Dec 27, 2024, 01:25 | Blog
A festive message from ELPA president - Marko Korenjak
European Liver Patients'​ Association - ELPA shared a post on LinkedIn: "A Festive Message from…
Dec 19, 2024, 02:47 | Blog
Liver cancer treatment through radioembolization - IMAGIO
IMAGIO project shared a post on LinkedIn: "New research from the IMAGIO Project highlights advanced…
Dec 18, 2024, 03:36 | Blog
Marina Uchenik: Our Animated Patient Guide to Liver Cancer
Marina Uchenik, Operations Manager at Blue Faery: The Adrienne Wilson Liver Cancer Association, shared a…
Dec 12, 2024, 15:45 | Blog
Marko Korenjak: Uniting for a Stronger Patient Voice - Tackling NCDs Together
European Liver Patients'​ Association - ELPA shared a post on LinkedIn: "European Liver Patients'​ Association…
Dec 10, 2024, 18:29 | Blog
Milan Mishkovikj: Clinical insight into liver diseases and HIV/AIDS
Milan Mishkovikj, President of the National Alliance of Patient Organizations (NAPO), shared a post on…
Dec 10, 2024, 17:04 | Blog
Han Chong Toh: The greatest gathering of GI cancer leaders
Han Chong Toh, Deputy CEO of the National Cancer Centre Singapore, shared a post by…
Dec 9, 2024, 14:41 | Blog
Together, We Rise, Prevail and Save Lives - European Liver Patients' Association
European Liver Patients' Association shared a post on X: "United for Change. From cutting-edge EU-funded…
Dec 5, 2024, 17:28 | Blog
Turning Liver Cancer from a Public Health Challenge into a Story of Hope by Marko Korenjak - European Liver Patients​ Association
European Liver Patients'​ Association - ELPA shared a post on LinkedIn: "UNITED FOR CHANGE From…
Nov 27, 2024, 18:01 | Blog
Boston Scientific Expands Oncology Portfolio with Acquisition of Intera Oncology
Boston Scientific has announced its agreement to acquire Intera Oncology® Inc., a company known for…
Nov 26, 2024, 19:47 | Blog
Liver Cancer: A European Public Health Challenge - European Liver Patients'​ Association
European Liver Patients'​ Association (ELPA) shared a post on LinkedIn: "Liver Cancer: A European Public…
Nov 24, 2024, 05:16 | Insight
Francesco Torselli shining a Spotlight on Liver Cancer Awareness - ELPA
European Liver Patients'​ Association - ELPA shared on LinkedIn: "Shining a Spotlight on Liver Cancer…
Nov 10, 2024, 03:35 | Blog
Katie Coleman: Three years since my last cancer-related intervention
Katie Coleman, Product and Engineering Lead at the Rare Cancer Research Foundation, shared a post…
Nov 7, 2024, 11:37 | Insight
Atezolizumab/bevacizumab and lenvatinib for HCC
Arndt Vogel shared the following post on X: "Hot off the press - our European RWD…
Oct 28, 2024, 14:56 | Blog
Shaibu Issa: Creating a future where liver cancer is no longer a death sentence
Shaibu Issa, Member HBV Global Community Advisory Board (HBV-CAB) at Hepatitis B Foundation, shared a…
Oct 27, 2024, 13:07 | Blog
Shaibu Issa: Be the change that you want to see by telling people about HBV
Shaibu Issa, Global Hepatitis B Advocate, shared a post on LinkedIn: "Be the change that…
Oct 17, 2024, 17:51 | Blog
Shahrin Ahmed: Liver Cancer Awareness Month
Shahrin Ahmed, Medical Specialist at Canadian Cancer Society, shared a post on X: ''Liver Cancer…
Oct 17, 2024, 16:58 | Blog
Liver Cancer Awareness Month: Recognizing Early Signs is Key - IMAGIO Project
IMAGIO Project shared a post on LinkedIn: "Liver Cancer Awareness Month: Recognizing Early Signs is Key…
Oct 16, 2024, 15:31 | Blog
Laura Vater: Clinicians with the highest empathy levels and patient satisfaction scores are at a higher risk of burnout
Laura Vater shared a post on X: "Clinicians with the highest empathy levels and patient…
Oct 11, 2024, 13:36 | Insight
Sarah Miremadi: Some of the latest advancements in liver cancer treatment
Sarah Miremadi, Researcher at Regenerative Medicine Department of Royan Institute, shared a thread on X:…
Oct 7, 2024, 07:58 | Blog
October is Liver Cancer Awareness Month
Liver Cancer Awareness Month, observed every October, serves as a crucial platform to raise awareness…
Oct 5, 2024, 13:35 | Insight
SI kinase to act as a key signaling mediator of a rare fusion oncogene involved in fibrolamellar carcinoma
Kei Sakamoto, Vice Director of  Novo Nordisk Foundation, shared a post by Elizabeth McKenna, on…
Oct 3, 2024, 07:41 | Blog
Justin Stebbing: The role alcohol plays in new cancer cases
Justin Stebbing shared at theconversation.com: “A little bit of alcohol was once thought to be…
Oct 3, 2024, 07:30 | Insight
Wafik S. El-Deiry: Rising mortality rate from Liver and Bile Duct Cancer in Rhode Island for unclear reasons
Wafik S. El-Deiry shared a post on X: "We have a rising mortality rate from…
Sep 28, 2024, 15:56 | Blog
Yasmine Hassan: Liver cancer is the 6th most common cancer worldwide
Yasmine Hassan, Global Patient Affairs Director at AstraZeneca, shared the following on LinkedIn: “Liver cancer is…
Sep 27, 2024, 14:25 | Blog
Join Fraunhofer IZI at the Leipzig Immune Oncology Conference 2024
Florian Lordick, Professor of Medicine at University of Leipzig, shared a post by Fraunhofer IZI, on…
Sep 21, 2024, 13:02 | Blog
Final OS data from the phase III CONTACT-02 trial at ESMO24
ESMO (European Society for Medical Oncology) shared a post on LinkedIn: ''Final OS data from…
Aug 31, 2024, 00:14 | Insight
Evelyn Wong: The 11th Asia Pacific Gastroenterology Cancer Summit
Evelyn Wong, Medical Oncologist at National Cancer Centre Singapore, shared a post on LinkedIn: “Where would…
Aug 25, 2024, 09:39 | Insight
Neratinib with or without Immune Checkpoint Inhibitors in Fibrolamellar Carcinoma
Arndt Vogel shared a post on X: "Neratinib Alone or with Immune Checkpoint Inhibitors with…
Aug 21, 2024, 14:33 | Blog
Manel Esteller: Proud mentor moment
Manel Esteller, Director at Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL),…
Jul 28, 2024, 14:14 | Blog
Today is World Hepatitis Day - European Cancer Organisation
European Cancer Organisation (ECO) shared on LinkedIn: "Today is World Hepatitis Day! ECO stands with…
Jul 28, 2024, 13:02 | Insight
Recognising the people impacted by hepatitis this Hepatitis Awareness Week - Cancer Institute NSW
Cancer Institute NSW shared a post on LinkedIn: "This Hepatitis Awareness Week we are recognising…
Jul 16, 2024, 20:15 | Blog
Ghassan Abou-Alfa: The struggle of HCC liver cancer of the different islands and atolls of the Pacific Ocean
Ghassan Abou-Alfa, Associate Attending at Memorial Sloan Kettering Cancer Center, shared a post on X:…
Jul 8, 2024, 18:50 | Blog
Tumor Board Tuesday on Durva + TACE for HCC
Tumor Board Tuesday published the following post on X: “Did you know that there are…
Jul 2, 2024, 09:01 | Societies
Key points from ESMOGI24 by Arndt Vogel
ESMO GI 2024 is held in Munich, Germany, and online from June 26-29. Organized by…
Jun 27, 2024, 02:53 | Blog
Tanja Obradovic: Tempest Therapeutics just announced very good results from ongoing global clinical study with Amezalpat
Tanja Obradovic shared on LinkedIn: . “Are we to expect completely new mechanism of action…
Jun 16, 2024, 15:58 | Insight
SBRT and liver transplant in previously untreated unresectable hepatocellular carcinoma
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a post on…
Jun 9, 2024, 08:15 | Cancer Types
Liver Cancer: What patients should know about
Introduction Liver cancer is a serious condition that occurs when abnormal cells in the liver grow uncontrollably. It can be classified into…
Jun 7, 2024, 13:51 | Blog
Nishwant Swami: Incredibly proud of Joyce Tien for leading our piece on the importance of disaggregation
Nishwant Swami, Internal Medicine Resident Physician at the Hospital of the University of Pennsylvania, shared…
May 21, 2024, 03:45 | Blog
Susanna Greer: Outsmarting liver cancer with a double whammy
Susanna Greer, Chief Scientific Officer at the V Foundation for Cancer Research, published the following…
May 19, 2024, 10:35 | Blog
Aisling Barry: Thrilled to now offer liver SBRT for patients with liver cancer at Cork University Hospital
Aisling Barry, Professor and Chair of Radiation Oncology at University College Cork, posted on LinkedIn:…
May 8, 2024, 02:47 | Blog
Cecilia Monge: Very proud of Gabriela Arroyo Figueroa presenting her work at NIH Postbac Poster Day 2024
Cecilia Monge, Safety Review Committee at National Cancer Institute, shared a post on LinkedIn: "NIH Postbac…
May 2, 2024, 15:29 | Blog
Zainab Shinkafi-Bagudu: As we mark Immunization Week, let's give a nod to unsung heroes
Zainab Shinkafi-Bagudu shared on LinkedIn: "As we come to the end of Immunization Week, I'm reminded…
Apr 25, 2024, 11:47 | Blog
Cecilia Monge B.: The Importance of Health Disparities in Liver Cancer in the Hispanic Population
Cecilia Monge B., Safety Review Committee at National Cancer Institute, shared a post on LinkedIn: "The Importance…
Apr 21, 2024, 18:27 | Insight
Aradhana Kasimsetty: Denise Sabatino and I present a review of the known risks of AAV vector-mediated liver cancer
Aradhana Kasimsetty, Doctoral Candidate at the Perelman School of Medicine, shared on LinkedIn: “With the recent…
Apr 16, 2024, 20:44 | Insight
Paper summary by Erman Akkus
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Incidence and mortality of…
Apr 13, 2024, 13:05 | Insight
Amy Moore: Taking steps for cancer risk reduction
Amy Moore, VP of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared a post…
Apr 11, 2024, 16:08 | Insight
New Paper Alert! Exploring the Genomic Diversity of Cancer in Latin American Populations
Exploring the Genomic Diversity of Cancer in Latin American Populations Authors: Alejandro Ruíz-Patiño, Leonardo Rojas,…
Apr 10, 2024, 09:32 | Insight
New Article Alert! New Findings on Personalized Vaccine and Pembrolizumab for Liver Cancer Treatment
New Findings on Personalized Vaccine and Pembrolizumab for Liver Cancer Treatment Authors: Mark Yarchoan, Edward…
Apr 5, 2024, 16:16 | Blog
Sharlene Gill: Excited to be a faculty participant for the 14th Annual Asia-Pacific Primary Liver Cancer Expert Meeting
Sharlene Gill shared on LinkedIn: ''Excited to be a faculty participant for the 14th Annual Asia-Pacific…
Apr 5, 2024, 05:05 | Blog
David Fajgenbaum: I had a PET scan to look into my Castleman disease, and the scan came back completely clear
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared a…
Feb 27, 2024, 05:27 | Blog
Shubh Goel: Recently, I spoke to a Pharmaceutical Executive following data presented at ASCO GI from our EMERALD-1 and MATTERHORN Phase III trials
Shubh Goel, VP and US Franchise Head, Immuno-Oncology and GI Tumors at AstraZeneca, shared a…
Feb 8, 2024, 05:23 | Blog
Khalis Mustafayev: Our recent article, co-authored with Dr. Vincent Mallet and Dr. Harrys Torres is now published in the Journal of Immunotherapy and Precision Oncology
Khalis Mustafayev, Postdoctoral FellowPostdoctoral Fellow at MD Anderson Cancer Center, recently shared on LinkedIn: "Exciting…
Jan 11, 2024, 07:19 | History
Less Survivable Cancers Awareness Day
On January 11th each year, the United Kingdom recognizes Less Survivable Cancers Awareness Day, focusing…
Sep 29, 2023, 19:01 | Insight
Pashtoon Kasi: N-of-1 Precision Medicine: This story is very dear to my heart.
Quoting Pashtoon Kasi, The Director of Colon Cancer Research at Weill Cornell Medicine, on X/Twitter: “N-of-1…
Aug 16, 2023, 19:43 | Drugs
Arndt Vogel: FDA approves Melphalan as a liver-directed treatment for uveal melanoma.
Arndt Vogel, Head of the GI-Cancer Center and of the Center for Personalized Medicine at…
Aug 9, 2023, 21:00 | Drugs
Atezolizumab/bevacizumab for the management of HCC in 1st setting - Arndt Vogel
🔥 off the press: Atezolizumab/bevacizumab for the management of HCC in 1st setting: systematic literature…
Jul 29, 2023, 19:39 | Blog
By increasing hepatitis testing, we can save more lives - Todd Harper
Our Victorian Cancer Registry shows liver cancer is the sixth most common cause of cancer…
All: 92 Posts: 1 - 100
Special Coverage